First new planned US nuclear reactors likely to get government loans, energy chief says

U.S. Energy Secretary Chris Wright said the first five to 10 new planned U.S. nuclear reactors will "almost certainly" receive loans from the Energy Department’s lending office, with nearly $290 billion available to lend. The policy backdrop is supportive for nuclear developers and suppliers, especially Westinghouse-linked projects and uranium exposure such as CCJ, even though no large reactors are currently approved and recent U.S. projects were delayed by about seven years and ran roughly $17 billion over budget.

Analysis

This is not just a nuclear-bullish headline; it is a financing signal that lowers the biggest gating item for the first wave of new U.S. reactor starts. The edge is less in the eventual buildout itself than in the policy-backed de-risking of capital, which should pull forward ordering activity for long-lead components and engineering services before first concrete is poured. That creates a multi-year revenue visibility window for upstream suppliers, while the core build risk remains concentrated in a handful of project sponsors and EPC players.

The second-order winner is the nuclear fuel cycle, especially names with leverage to a durable domestic build pipeline and enrichment/uranium demand normalization. A credible U.S. reactor restart cycle would tighten the market not only for uranium but also for converter/enrichment bottlenecks, which are more fragile than the headline commodity market suggests. That means the trade may express better through supply-chain scarcity than through pure reactor-equipment beta.

The market is likely underestimating schedule risk: government financing reduces funding risk, but it does not solve permitting, labor, supply chain, or execution slippage. Historically, the bigger the policy push, the more likely the first projects become showcases rather than scalable templates, so the near-term upside is mostly in sentiment and contract awards, not immediate earnings. The contrarian view is that the real trade is a volatility premium on the ecosystem, because any delay, cost overrun, or regulatory rollback would hit the cohort hard after a short-lived rerating.

For BAM, the angle is more about embedded option value in infrastructure capital deployment than operating leverage; for CCJ, the convexity comes from a longer-duration fuel demand story. SMCI and APP look like incidental comparisons here and do not appear directly levered to this catalyst, so the cleaner expression is nuclear supply chain rather than AI adjacency. If this policy support continues, the next leg likely comes from specific project awards and EPC contracts, not from the headline itself.

Key Decisions for Investors

• Buy CCJ on weakness over the next 1-3 weeks as a way to express the uranium/fuel-cycle scarcity trade; target a 10-15% upside over 3-6 months with policy support, but trim if reactor announcements fail to appear by mid-year.
• Add BAM selectively on a 6-12 month horizon as a financing-and-platform beneficiary of large-scale infrastructure deployment; use dips to build, with a favorable risk/reward if capital allocation into nuclear and related infrastructure accelerates.
• Pair trade: long CCJ / short a basket of high-beta industrials exposed to execution risk in new nuclear buildouts; this isolates fuel-cycle leverage versus construction overoptimism.
• Avoid chasing reactor-equipment names at current levels unless there is a specific contract catalyst; the better entry is after first award wins, because the first rerate is likely to fade on schedule-risk headlines.
• If available, buy 3-6 month calls on CCJ rather than common stock to capture policy-driven convexity with defined downside; this is a cleaner expression than broad energy exposure.